Optical Wi-Fi allows for ultrafast underwater communications

Published:22.09.20 — EPFL spin-off Hydromea has developed a miniature optical modem that can operate down to 6,000 meters below the ocean’s surface. It is sensitive enough to collect data at very high speeds from sources more than 50 meters away.

A link between sensory neurons activation and the immune system

Published:21.09.20 — Scientists at EPFL, ETH Zurich and Harvard Medical School/Boston Children’s Hospital have developed an implantable technology that enabled the discovery of an interaction between sensory neurons and immune cells.

An acoustically actuated microscopic device

Published:21.09.20 — Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy.

Synthetic biology: a discussion with George Church and Christian Frei

Published:18.09.20 — In his latest science documentary Genesis 2.0, Swiss movie director Christian Frei offers a perspective on how people around the world are pushing the limits of synthetic biology towards their vision of a new beginning, a second Genesis. The movie will be screened at EPFL’s Forum Rolex on September 25th, followed by discussions with eminent figures, including the movie’s director and Harvard synthetic biologist George Church.

Patches to detect when a viral disease is about to get worse

Published:18.09.20 — Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin™ sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.